Drug
Procarbazine Hydrochloride
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Blood Count Abnormal | 132 | 40.4 | 41.6 | signal |
| 2 | Full Blood Count Abnormal | 39 | 17.3 | 17.5 | signal |
| 3 | Hepatic Cytolysis | 42 | 16.1 | 16.2 | signal |
| 4 | Platelet Count Decreased | 239 | 10.5 | 11.0 | signal |
| 5 | White Blood Cell Count Decreased | 229 | 9.9 | 10.4 | signal |
| 6 | Myelodysplastic Syndrome | 28 | 9.1 | 9.1 | signal |
| 7 | Nerve Injury | 21 | 8.8 | 8.8 | signal |
| 8 | Polyneuropathy | 15 | 5.9 | 5.9 | signal |
| 9 | Nausea | 973 | 5.8 | 7.1 | signal |
| 10 | Constipation | 265 | 5.7 | 6.0 | signal |
| 11 | Red Blood Cell Count Decreased | 31 | 5.1 | 5.1 | signal |
| 12 | Fatigue | 829 | 5.0 | 5.9 | signal |
| 13 | Stomatitis | 63 | 4.9 | 4.9 | signal |
| 14 | Neutropenia | 132 | 4.6 | 4.7 | signal |
| 15 | Blood Test Abnormal | 13 | 4.3 | 4.3 | signal |
| 16 | Thrombocytopenia | 100 | 4.2 | 4.3 | signal |
| 17 | Disease Progression | 95 | 3.8 | 3.8 | signal |
| 18 | Decreased Appetite | 177 | 3.6 | 3.7 | signal |
| 19 | Respiratory Disorder | 21 | 3.3 | 3.3 | signal |
| 20 | Mucosal Inflammation | 18 | 3.2 | 3.2 | signal |
| 21 | Cytopenia | 8 | 3.1 | 3.1 | signal |
| 22 | Neutrophil Count Decreased | 27 | 3.1 | 3.1 | signal |
| 23 | Neuropathy Peripheral | 63 | 3.1 | 3.1 | signal |
| 24 | Febrile Neutropenia | 44 | 3.1 | 3.1 | signal |
| 25 | Acute Hepatic Failure | 9 | 3.1 | 3.1 | signal |
| 26 | Herpes Zoster | 38 | 3.1 | 3.1 | signal |
| 27 | Vomiting | 304 | 3.0 | 3.2 | signal |
| 28 | Haematotoxicity | 6 | 3.0 | 3.0 | signal |
| 29 | Bone Marrow Failure | 13 | 3.0 | 3.0 | signal |
| 30 | Urticaria | 103 | 2.9 | 2.9 | signal |
| 31 | Septic Shock | 24 | 2.6 | 2.6 | signal |
| 32 | Full Blood Count Decreased | 11 | 2.5 | 2.6 | signal |
| 33 | Pancytopenia | 30 | 2.5 | 2.5 | signal |
| 34 | Myocardial Ischaemia | 6 | 2.4 | 2.4 | no signal |
| 35 | Lymphoma | 8 | 2.4 | 2.4 | signal |
| 36 | Acute Myeloid Leukaemia | 8 | 2.4 | 2.4 | signal |
| 37 | Leukopenia | 25 | 2.3 | 2.3 | signal |
| 38 | Rash Generalised | 13 | 2.3 | 2.3 | signal |
| 39 | Mouth Ulceration | 10 | 2.2 | 2.2 | signal |
| 40 | Neoplasm Progression | 16 | 2.1 | 2.1 | signal |
| 41 | Bone Pain | 26 | 2.1 | 2.1 | signal |
| 42 | Agranulocytosis | 8 | 2.0 | 2.0 | no signal |
| 43 | Osteonecrosis | 14 | 2.0 | 2.0 | no signal |
| 44 | Toxic Skin Eruption | 4 | 1.8 | 1.8 | no signal |
| 45 | Laboratory Test Abnormal | 11 | 1.7 | 1.7 | no signal |
| 46 | Hepatocellular Injury | 5 | 1.6 | 1.6 | no signal |
| 47 | Visual Acuity Reduced | 11 | 1.5 | 1.5 | no signal |
| 48 | Brain Neoplasm | 3 | 1.5 | 1.5 | no signal |
| 49 | Cytomegalovirus Infection | 5 | 1.4 | 1.4 | no signal |
| 50 | Pneumocystis Jirovecii Pneumonia | 3 | 1.4 | 1.4 | no signal |
| 51 | Malignant Neoplasm Progression | 28 | 1.3 | 1.3 | no signal |
| 52 | Myelosuppression | 8 | 1.1 | 1.1 | no signal |
| 53 | Drug Toxicity | 3 | 1.0 | 1.0 | no signal |
| 54 | Hepatic Cancer | 5 | 1.0 | 1.0 | no signal |